What is RNA in cancer?
In cancer, various noncoding RNAs are dysregulated, which in many cases is suspected to drive tumor growth or metastasis. Close correlations have been determined between patient outcomes and levels of certain long noncoding RNAs in their tumors.
Is RNA used for cancer treatment?
RNA therapy mainly includes ASO, RNAi and mRNA therapy. A variety of mechanisms of RNA therapy work on target RNAs expression to cure diseases. RNA therapy destroys tumor cells by inhibiting proliferation and metastasis, and inducing apoptosis.
What is the difference between coding and non-coding RNA?
Coding RNAs generally refers to mRNA that encodes protein ① to act as various components including enzymes, cell structures, and signal transductors. Noncoding RNAs act as cellular regulators without encoding proteins ③.
What is Linc RNA?
Long intergenic non-coding RNAs (lincRNAs) are defined as RNA transcripts that are longer than 200 nucleotides. LincRNAs also contain promoter- or enhancer-associated RNAs that are gene proximal and can be either in the sense or antisense orientation, relative to the protein-coding gene with which they are associated.
Do long noncoding RNAs play a role in cancer?
DOI: 10.1158/0008-5472.CAN-16-2634 Abstract In addition to mutations or aberrant expression in the protein-coding genes, mutations and misregulation of noncoding RNAs, in particular long noncoding RNAs (lncRNA), appear to play major roles in cancer.
How many long noncoding RNA (lncRNA) are there?
On the basis of the ENCODE project, it is estimated that the human genome encodes more than 28,000 distinct long noncoding RNAs (lncRNA), many of which are still being discovered and are yet to be annotated ( 6 ).
Do lncRNAs play a role in cancer development?
Genome-wide association studies of tumor samples have identified a large number of lncRNAs ass … In addition to mutations or aberrant expression in the protein-coding genes, mutations and misregulation of noncoding RNAs, in particular long noncoding RNAs (lncRNA), appear to play major roles in cancer.
Do lncRNAs mediate drug resistance in cancer cells?
Over the last decade, it has been reported that 1ong noncoding RNAs (lncRNAs) can mediate carcinogenesis and drug resistance/sensitivity in cancer cells. This article reviews, in detail, recent studies regarding the roles of lncRNAs in mediating drug resistance.
